Reducing Transcranial Direct Current Stimulation‐Induced Erythema With Skin Pretreatment: Considerations for Sham‐Controlled Clinical Trials

ConclusionsKetoprofen 2% topical pretreatment might be an interesting strategy to reduce tDCS‐induced erythema and might be useful for blinding improvement in further sham‐controlled tDCS trials.

Source: Neuromodulation - August 1, 2014 Category: Neurology Authors: Fabiana Guarienti, Wolnei Caumo, Pedro Shiozawa, Quirino Cordeiro, Paulo S. Boggio, Isabela M. Benseñor, Paulo A. Lotufo, Marom Bikson, André R. Brunoni Tags: Clinical Research Source Type: research